Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation - PubMed (original) (raw)
. 1996 May 1;15(9):2174-83.
Affiliations
- PMID: 8641283
- PMCID: PMC450141
Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation
G Bunone et al. EMBO J. 1996.
Abstract
The estrogen receptor (ER) can be activated as a transcription factor either by binding of cognate estrogenic ligand or, indirectly, by a variety of other extracellular signals. As a first step towards elucidating the mechanism of 'steroid-independent activation' of the ER by the epidermal growth factor (EGF), we have mapped the ER target domain and determined the signaling pathway. We show that the N-terminal transcriptional activation function AF-1, but not the C-terminal AF-2, is necessary for the EGF response. Both the EGF-induced hyperphosphorylation and the transcriptional activation of the unliganded ER depend on a phosphorylatable serine residue at position 118. However, its phosphorylation is not sufficient and, hence, there must be other target domains or proteins which fulfill an additional requirement for EGF signaling through the ER. Using dominant-negative Ras and MAP kinase kinase (MAPK kinase) and constitutively active MAPK kinase mutants, we show that EGF activates the ER by signaling through the MAPK pathway suggesting that MAPK directly phosphorylates the critical serine 118. Our results also imply that the steroid-independent activation of a variety of ER mutants, which arise during the malignant progression of breast tumors, may contribute to tamoxifen resistance.
Similar articles
- Potentiation of estrogen receptor activation function 1 (AF-1) by Src/JNK through a serine 118-independent pathway.
Feng W, Webb P, Nguyen P, Liu X, Li J, Karin M, Kushner PJ. Feng W, et al. Mol Endocrinol. 2001 Jan;15(1):32-45. doi: 10.1210/mend.15.1.0590. Mol Endocrinol. 2001. PMID: 11145737 - Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase.
Kato S, Endoh H, Masuhiro Y, Kitamoto T, Uchiyama S, Sasaki H, Masushige S, Gotoh Y, Nishida E, Kawashima H, Metzger D, Chambon P. Kato S, et al. Science. 1995 Dec 1;270(5241):1491-4. doi: 10.1126/science.270.5241.1491. Science. 1995. PMID: 7491495 - pp90rsk1 regulates estrogen receptor-mediated transcription through phosphorylation of Ser-167.
Joel PB, Smith J, Sturgill TW, Fisher TL, Blenis J, Lannigan DA. Joel PB, et al. Mol Cell Biol. 1998 Apr;18(4):1978-84. doi: 10.1128/MCB.18.4.1978. Mol Cell Biol. 1998. PMID: 9528769 Free PMC article. - Cross-talk between peptide growth factor and estrogen receptor signaling pathways.
Smith CL. Smith CL. Biol Reprod. 1998 Mar;58(3):627-32. doi: 10.1095/biolreprod58.3.627. Biol Reprod. 1998. PMID: 9510949 Review. - Inhibition of erbB receptor (HER) tyrosine kinases as a strategy to abrogate antiestrogen resistance in human breast cancer.
Kurokawa H, Arteaga CL. Kurokawa H, et al. Clin Cancer Res. 2001 Dec;7(12 Suppl):4436s-4442s; discussion 4411s-4412s. Clin Cancer Res. 2001. PMID: 11916237 Review.
Cited by
- Sex steroid hormone residues in milk and their potential risks for breast and prostate cancer.
Gao P, Li C, Gong Q, Liu L, Qin R, Liu J. Gao P, et al. Front Nutr. 2024 Sep 2;11:1390379. doi: 10.3389/fnut.2024.1390379. eCollection 2024. Front Nutr. 2024. PMID: 39285863 Free PMC article. Review. - Stratifying risk of disease in haematuria patients using machine learning techniques to improve diagnostics.
Drożdż A, Duggan B, Ruddock MW, Reid CN, Kurth MJ, Watt J, Irvine A, Lamont J, Fitzgerald P, O'Rourke D, Curry D, Evans M, Boyd R, Sousa J. Drożdż A, et al. Front Oncol. 2024 May 8;14:1401071. doi: 10.3389/fonc.2024.1401071. eCollection 2024. Front Oncol. 2024. PMID: 38779086 Free PMC article. - DNA Damage Responses in Tumors Are Not Proliferative Stimuli, but Rather They Are DNA Repair Actions Requiring Supportive Medical Care.
Suba Z. Suba Z. Cancers (Basel). 2024 Apr 19;16(8):1573. doi: 10.3390/cancers16081573. Cancers (Basel). 2024. PMID: 38672654 Free PMC article. Review. - Alternative promoters and splicing create multiple functionally distinct isoforms of oestrogen receptor alpha in breast cancer and healthy tissues.
Balcazar Lopez CE, Albrecht J, Hafstað V, Börjesson Freitag C, Vallon-Christersson J, Bellodi C, Persson H. Balcazar Lopez CE, et al. Cancer Med. 2023 Sep;12(18):18931-18945. doi: 10.1002/cam4.6508. Epub 2023 Sep 7. Cancer Med. 2023. PMID: 37676103 Free PMC article. - CRISPR-Cas9 screen reveals a role of purine synthesis for estrogen receptor α activity and tamoxifen resistance of breast cancer cells.
Hany D, Vafeiadou V, Picard D. Hany D, et al. Sci Adv. 2023 May 12;9(19):eadd3685. doi: 10.1126/sciadv.add3685. Epub 2023 May 12. Sci Adv. 2023. PMID: 37172090 Free PMC article.
References
- J Steroid Biochem Mol Biol. 1994 Apr;48(5-6):481-6 - PubMed
- EMBO J. 1987 May;6(5):1309-15 - PubMed
- J Biol Chem. 1995 Mar 10;270(10):5594-9 - PubMed
- Breast Cancer Res Treat. 1994;32(1):49-55 - PubMed
- Science. 1993 Nov 12;262(5136):1069-72 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials